Zydus Lifesciences Appoints Vikram Shukla as President-Parenteral Operations

Team Finance Saathi

    03/Jan/2025

What's covered under the Article:

  1. Zydus Lifesciences announces the appointment of Vikram Shukla as President-Parenteral Operations.
  2. Shukla brings 29 years of expertise in injectable formulations and regulatory compliance.
  3. The appointment supports Zydus Lifesciences' growth strategy in the injectable business.

On January 3, 2025, Zydus Lifesciences Limited announced the appointment of Mr. Vikram Shukla as the President of Parenteral Operations, designating him as a Senior Management Personnel. This decision, made by the company's board of directors following the recommendation of the Nomination and Remuneration Committee, reflects the company’s strategic move to expand its injectable business and enhance its leadership in this rapidly growing segment.

Mr. Shukla, aged 51, brings with him over 29 years of extensive experience in formulations and Active Pharmaceutical Ingredients (API), particularly for injectables catering to US and EU requirements. With a background in regulatory audits, manufacturing, and quality operations management, his expertise will be pivotal in supporting Zydus' ambitious growth plans.

Before his appointment at Zydus, Mr. Shukla held the role of Vice President, Operations-Sterile Injectable and Biotech Operations at Pfizer Inc. in the APAC region. His previous work experience spans several prominent pharmaceutical companies, including Dr. Reddy's Laboratories, Lupin, Nicolas Piramal, and Zydus Hospira Oncology JV, providing him with a solid foundation in injectable business management.

Zydus Lifesciences has expressed confidence that Mr. Shukla’s leadership will help the company streamline its operations and capitalize on the growing market for injectable products. The company’s move to appoint a dedicated senior leader in this space highlights its commitment to expanding its injectable business to meet increasing global demand.

This appointment is aligned with Zydus Lifesciences' ongoing efforts to strengthen its leadership in critical therapeutic areas and maintain its competitive edge in the pharmaceutical industry.

The Upcoming IPOs in this week and coming weeks are Indobell InsulationStandard Glass LiningQuadrant FutureCapital Infra Trust, Delta AutocorpB R Goyal.

The Current active IPO is   Fabtech Technologies, Leo Dry FruitsDavin Sons, and Parmeshwar Metal.

For more updates on executive appointments and other business developments, we encourage readers to explore related news and articles, including the latest on IPOsshare market updates, and financial strategies at:
Best IPO to Apply Now - IPO List 2024, Latest IPO, Upcoming IPO, Recent IPO News, Live IPO GMP Today - Finance Saathi
Top News Headlines - Share Market News, Latest IPO News, Business News, Economy News- Finance Saathi.

Join our Trading with CA Abhay Telegram Channel for regular Stock Market Trading and Investment Calls by CA Abhay Varn - SEBI Registered Research Analyst & Finance Saathi Telegram Channel for Regular Share Market, News & IPO Updates.

Start your Stock Market Journey and Apply in IPO by Opening Free Demat Account in Choice Broking FinX.

Related News
onlyfans leakedonlyfan leaksonlyfans leaked videos